← Back

Balchem Corporation

Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.

Country
Price · split & dividend adjusted
News & notes moving BCPC
BCPC

Conestoga Capital Advisors says Balchem’s 8% sales growth shows resilience despite Gulf war cost fears

Conestoga Capital Advisors highlighted Balchem Corporation in its second-quarter 2026 investor letter, noting that the specialty ingredients maker posted an 8% increase in first-quarter sales. The firm said the stock underperformed despite solid results because investors focused on potential higher costs tied to the war in the Gulf, and elevated expectations left little room for upside. Conestoga added that the fundamentals supporting its investment thesis remain intact, citing Balchem’s leadership in niche markets and consistent execution. Balchem shares closed at $178.79 on August 5, 2026, with a one-month return of 9.33% and a 12.13% gain over the past 52 weeks, giving it a market capitalization of $5.7 billion.
BCPC
Insider Monkey·43dRead more →
BCPC▲2

Balchem Q2 Non-GAAP EPS beats estimates by $0.06, revenue up 11.2%

Balchem Corporation reported second-quarter 2026 financial results that exceeded analyst expectations. Non-GAAP earnings per share came in at $1.49, beating estimates by $0.06, while revenue reached $284 million, an 11.2% increase year-over-year and $15.5 million above consensus. Cash flows from operations were $46.7 million, with free cash flow of $36.2 million. Adjusted EBITDA rose 12.6% from the prior year quarter to $77.9 million.
BCPC ▲
Seeking Alpha·49dRead more →
© 2026 MarketDXAsset